These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 25737131

  • 1. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
    Yu T, Meng N, Chi D, Zhao Y, Wang K, Luo Y.
    Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
    Kim SJ, Pak K, Kim K.
    Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Xiao Y, Wang L, Jiang X, She W, He L, Hu G.
    Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of FDG-PET versus magnetic resonance imaging for detecting spondylitis: a systematic review and meta-analysis.
    Yin Y, Liu X, Yang X, Guo J, Wang Q, Chen L.
    Spine J; 2018 Dec; 18(12):2323-2332. PubMed ID: 30121323
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X, Li Y, Liu B, Xu Z, Bao L, Wang J.
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [Abstract] [Full Text] [Related]

  • 6. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
    Liu F, Zhang Q, Zhu D, Liu F, Li Z, Li J, Wang B, Zhou D, Dong J.
    Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
    [Abstract] [Full Text] [Related]

  • 7. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
    Wu LM, Hu JN, Hua J, Gu HY, Zhu J, Xu JR.
    J Gastroenterol Hepatol; 2012 Mar; 27(3):472-80. PubMed ID: 21916986
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Wei J, Pei S, Zhu X.
    Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
    [Abstract] [Full Text] [Related]

  • 9. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY, Lin CL, Kao CH.
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [Abstract] [Full Text] [Related]

  • 10. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K, Kawasaki H, Sato M, Koyama K, Yoshimi F, Nagai H.
    Dig Surg; 2017 Oct; 34(1):60-67. PubMed ID: 27454870
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
    Zou Y, Tong J, Leng H, Jiang J, Pan M, Chen Z.
    Oncotarget; 2017 Jun 20; 8(25):41518-41528. PubMed ID: 28514747
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y, Li P, Zhang H, Shi Y, Wu H, Zhang J, Qian Y, Li C, Yang J.
    Int J Cancer; 2013 Jan 15; 132(2):E37-47. PubMed ID: 22890912
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.
    Zhang C, Chen Y, Xue H, Zheng P, Tong J, Liu J, Sun X, Huang G.
    Int J Cancer; 2009 Jan 01; 124(1):167-73. PubMed ID: 18844237
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis.
    Zhao JY, Ma XL, Li YY, Zhang BL, Li MM, Ma XL, Liu L.
    Asian Pac J Cancer Prev; 2014 Jan 01; 15(8):3525-31. PubMed ID: 24870751
    [Abstract] [Full Text] [Related]

  • 15. The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis.
    Zhang Q, Xi Y, Li D, Yuan Z, Dong J.
    J Orthop Surg Res; 2020 Jun 22; 15(1):229. PubMed ID: 32571371
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake: a systematic review and meta-analysis.
    Son GM, Kim SJ.
    Abdom Radiol (NY); 2019 Feb 22; 44(2):456-463. PubMed ID: 30132094
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
    Goense L, van Rossum PS, Reitsma JB, Lam MG, Meijer GJ, van Vulpen M, Ruurda JP, van Hillegersberg R.
    J Nucl Med; 2015 Jul 22; 56(7):995-1002. PubMed ID: 25952733
    [Abstract] [Full Text] [Related]

  • 18. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW, Nam SB, Kim SJ.
    Oncology; 2019 Jul 22; 97(5):286-293. PubMed ID: 31437839
    [Abstract] [Full Text] [Related]

  • 19. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer.
    Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Ell P.
    Eur J Nucl Med; 2001 Dec 22; 28(12):1758-65. PubMed ID: 11734912
    [Abstract] [Full Text] [Related]

  • 20. High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature.
    Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen HB, Haldorsen IS.
    J Nucl Med; 2016 Jun 22; 57(6):879-85. PubMed ID: 26823564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.